| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |